UF College of Pharmacy ranked No. 3 nationally in NIH funding
The college’s investigators earned $19.4 million in NIH awards in 2025, according to the Blue Ridge Institute for Medical Research.
Posted in
News
Dr. Maddalena Parafati selected for Research Promotion Initiative funding
The University of Florida’s Office of Strategic Communications and Marketing selected a paper authored by Maddalena Parafati, Ph.D., research assistant professor of cellular and systems pharmacology in the UF College of Pharmacy, for its Research Promotion Initiative funding. The highly competitive contest awards $1,000 for accepted research highlighting important…
Dr. Thomas Burris named recipient of the Louis S. Goodman and Alfred Gilman Award in Receptor Pharmacology
The Goodman and Gilman Award is presented biennially by the American Society for Pharmacology and Experimental Therapeutics, and Burris is the 24th recipient of this honor.
UF College of Pharmacy hosts 39th Annual Research Showcase
Students, trainees, faculty and staff from the University of Florida College of Pharmacy filled the Reitz Union on Feb. 9 for the 39th Annual Research Showcase.
Symposium showcases how in-space biomanufacturing could transform health on Earth and beyond
Nearly 100 scientists, industry leaders and government partners convened for the University of Florida’s second annual Biomanufacturing in Space Symposium on Nov. 6 in Orlando.
UF scientist studies muscle loss in space to benefit astronauts and patients on Earth
A new study led by UF researcher Siobhan Malany, Ph.D., sheds light on how human biology changes in microgravity.
$5 million funds innovation of more-potent opioid overdose antidote
A study supported by Dr. Jay McLaughlin aims to accelerate the drug development timeline for enhanced version of naloxone.
UF College of Pharmacy Researcher Wins Prestigious Global 3Rs Award
Jeffrey Thinschmidt has been awarded the 2025 IQ Consortium and AAALAC International Global 3Rs Award for the Americas.
Tic-related behaviors in Celsr3 mutant mice are contributed by alterations of striatal D3 dopamine receptors
Using mouse models, Dr. Marco Bortolato and his lab showed in Molecular Psychiatry that CELSR3, a high-confidence risk gene for Tourette syndrome, leads to tic-like behaviors by altering the distribution of dopamine D3 receptors. These data point to D3 receptors as a promising therapeutic target in Tourette syndrome.
Dr. Leslie Sombers’ research earns ACS Chemical Neuroscience cover feature
ACS Chemical Neuroscience chose artwork from Dr. Leslie Sombers’ latest publication to appear on the journal’s cover.
